Before you acquire an IV hydration clinic, verify every clinical, regulatory, and financial detail — one missed compliance issue can collapse a deal or trigger post-close liability.
Acquiring an IV therapy clinic means buying a cash-pay medical business operating at the intersection of healthcare regulation and consumer wellness. Unlike a traditional retail acquisition, due diligence here must cover state-specific corporate practice of medicine laws, medical director transferability, nurse licensing, compounding pharmacy compliance, and FDA oversight of infusion products — alongside standard financial and operational review. This checklist is designed for buyers evaluating clinics in the $1M–$5M revenue range, whether you are a first-time buyer using SBA financing or a platform operator executing a wellness rollup.
IV therapy clinics face a patchwork of state regulations governing medical supervision, nurse scope of practice, and compounded drug use. These items must be resolved before closing.
Verify all active state licenses, health department permits, and clinic certificates are current and transferable.
Expired or non-transferable permits can force a post-close shutdown before you generate a single dollar of revenue.
Red flag: Any lapsed license, pending renewal, or permit issued solely in the seller's personal name that cannot be assigned.
Confirm the clinic's structure complies with your state's corporate practice of medicine laws.
Many states prohibit non-physician entities from employing physicians or directing clinical care, requiring specific legal structures.
Red flag: A business entity structure that violates CPOM rules with no management services agreement or physician PC in place.
Review OSHA compliance documentation, sharps disposal records, and bloodborne pathogen training logs.
IV clinics handle needles and biohazardous materials daily — OSHA violations carry significant fines and reputational risk.
Red flag: Missing training records, no written exposure control plan, or prior OSHA citations on file.
Audit compounding pharmacy supplier relationships for FDA compliance and valid 503A or 503B registration.
Unregistered compounders supplying NAD+, glutathione, or high-dose vitamins expose you to FDA enforcement and product liability.
Red flag: Compounding pharmacy with no verifiable FDA registration or prior recall history for supplied infusion products.
The medical director is the clinical and regulatory backbone of an IV therapy clinic. Evaluating this agreement is the single most important step in healthcare-specific due diligence.
Obtain and review the full executed medical director agreement including duties, compensation, and term length.
A poorly structured or short-term agreement creates immediate post-close operational and regulatory risk.
Red flag: Month-to-month agreement with no notice period, or a physician who has already signaled intent to depart at close.
Confirm the agreement includes an assignability clause permitting transfer to a new ownership entity.
Without assignability, the agreement terminates at close and the clinic loses its supervising physician on day one.
Red flag: Agreement is silent on assignment or explicitly requires physician consent that has not been obtained.
Verify the medical director holds an active, unrestricted state medical license with no board complaints.
A restricted or lapsed license invalidates the supervision structure and may trigger immediate regulatory action.
Red flag: Any active board investigation, license restriction, or malpractice judgment against the supervising physician.
Assess whether the medical director is willing to remain engaged for at least 12 months post-close.
Physician continuity is essential for staff confidence, regulatory compliance, and operational stability during transition.
Red flag: Physician plans to exit at or shortly after closing with no identified replacement physician candidate.
Validate that reported earnings are real, recurring, and not dependent on conditions that disappear at close.
Review three years of accrual-based financial statements and confirm CPA preparation or review.
Cash-basis books common in small clinics can overstate or misrepresent profitability for SBA and buyer underwriting.
Red flag: Tax returns inconsistent with P&L, no CPA involvement, or revenue figures that cannot be reconciled to bank deposits.
Analyze membership program data including active member count, monthly recurring revenue, and trailing 12-month churn rate.
Membership revenue is the primary value driver — high churn destroys the predictability that justifies premium multiples.
Red flag: Fewer than 100 active members, churn above 8% monthly, or membership revenue below 20% of total clinic revenue.
Confirm average revenue per visit trends and identify any seasonal revenue concentration periods.
Clinics heavily dependent on holiday or summer spikes carry more revenue risk than year-round consistent performers.
Red flag: Revenue per visit declining year-over-year or more than 40% of annual revenue concentrated in a single quarter.
Identify any single client, employer wellness contract, or referral source generating more than 15% of revenue.
Concentrated revenue from a non-transferable contract disappears at close, immediately impacting the deal's economics.
Red flag: One corporate wellness client or concierge medicine referral partner representing over 20% of total annual revenue.
Licensed nurses and IV technicians are the day-to-day engine of the clinic. Evaluate staffing depth, credentials, and retention risk.
Request current licenses, certifications, and scope of practice documentation for all clinical staff.
Nurses administering IVs without proper licensure or outside their scope of practice create immediate liability exposure.
Red flag: Any unlicensed individual administering IV infusions or nurse licenses that are restricted or pending renewal.
Review malpractice insurance certificates for the clinic entity and all individual clinical providers.
Gaps in coverage leave you exposed to claims arising from adverse events that occurred pre-close.
Red flag: Occurrence-based policy recently switched to claims-made without a tail policy, or any unresolved malpractice claims.
Assess staff retention history and identify any nurses or providers who may not transition to new ownership.
High turnover in IV clinics is costly — losing key nurses at close can immediately impair service capacity.
Red flag: More than two clinical staff departures in the past 12 months or key nurses verbally tied to the selling owner.
Review written clinical protocols and standard operating procedures for all infusion services offered.
Documented protocols demonstrate clinical maturity, reduce liability, and are required for SBA lender healthcare review.
Red flag: No written SOPs, undocumented patient intake processes, or protocols that have never been reviewed by legal counsel.
IV clinics depend on reliable pharmaceutical and supply chains. Verify all key vendor relationships are documented and transferable.
Obtain all written supplier agreements for IV supplies, pharmaceuticals, and compounding pharmacy products.
Verbal supplier relationships break at close — undocumented agreements give vendors no obligation to serve the new owner.
Red flag: Key pharmaceutical supplier relationships are verbal only, or pricing agreements expire within 90 days of close.
Confirm all compounding pharmacy agreements include assignability provisions or vendor willingness to re-execute.
Compounding pharmacy relationships require credentialing — a lapse in supply disrupts every clinical service the clinic offers.
Red flag: Compounding pharmacy refuses to transfer the relationship or requires a new credentialing process taking 60+ days.
Review IV supply pricing and identify any volume-based discount thresholds the new owner must maintain.
Losing volume discounts post-close can meaningfully compress margins on a per-visit basis across all services.
Red flag: Pricing dependent on purchasing minimums that require multi-location volume the new single-location owner cannot meet.
Identify any sole-source dependencies for specialty infusion products like NAD+ or peptide compounds.
A single-source supplier for a premium service creates supply chain fragility that can suspend high-margin revenue overnight.
Red flag: NAD+ or peptide therapy revenue exceeding 20% of total sales with only one approved compounding pharmacy source.
Find IV Therapy Clinic Businesses For Sale
Vetted targets with diligence packages — skip the cold search.
The medical director agreement is the single most critical item. If it is not transferable, assignable, and backed by a physician willing to remain post-close, the entire clinical and regulatory structure of the business collapses on day one of new ownership. Confirm assignability, physician license status, and post-close commitment before spending material time on any other diligence category.
Yes, IV therapy clinics are generally SBA-eligible as cash-pay healthcare businesses, but lenders will conduct enhanced scrutiny on the medical director structure, state licensing compliance, and revenue concentration. A clean three-year financial history, a transferable medical director agreement, and documented membership revenue significantly improve SBA loan approval odds. Engage an SBA lender experienced in healthcare-adjacent transactions early in the process.
Many states prohibit non-physician entities from owning or controlling medical practices — a structure called the corporate practice of medicine doctrine. In affected states, you may need to acquire or create a physician-owned professional corporation and operate through a management services agreement that separates clinical from business functions. This is a legal requirement, not an option, and must be structured before close with a healthcare attorney familiar with your target state's specific rules.
A strong clinic will have 200 or more active members, monthly churn below 5%, and membership revenue representing at least 25–35% of total revenue. Month-over-month membership growth over the trailing 12 months is a positive signal, while flat or declining membership with high walk-in dependency suggests the business lacks the recurring revenue quality needed to support premium acquisition multiples in the 4x–5.5x EBITDA range.
More IV Therapy Clinic Guides
More Due Diligence Checklists
Stop cold-searching. Find signal-scored IV Therapy Clinic targets with seller motivation already identified.
Create your free accountNo credit card required
For Buyers
For Sellers